Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-08-17 22:08 | 2018-08-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $104.50 | 200,000 | $20,899,800 | 120,355,804 | -0.2% |
| 2018-08-16 21:52 | 2018-08-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $103.23 | 151,793 | $15,669,440 | 120,555,804 | -0.1% |
| 2018-08-13 22:41 | 2018-08-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $103.06 | 3,587 | $369,676 | 120,707,597 | 0.0% |
| 2018-08-08 20:28 | 2018-08-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $103.22 | 24,620 | $2,541,326 | 120,711,184 | 0.0% |
| 2018-08-07 18:46 | 2018-08-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $102.15 | 195,000 | $19,918,860 | 120,735,804 | -0.2% |
| 2018-08-03 21:31 | 2018-08-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $99.58 | 190,000 | $18,919,934 | 120,930,804 | -0.2% |
| 2018-08-01 20:12 | 2018-07-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $98.74 | 205,000 | $20,240,880 | 121,120,804 | -0.2% |
| 2018-07-27 20:58 | 2018-07-26 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $95.22 | 2,168 | $206,437 | 53,228 | +4.2% |
| 2018-07-26 21:17 | 2018-07-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $94.73 | 190,000 | $17,999,251 | 121,325,804 | -0.2% |
| 2018-07-25 18:47 | 2018-07-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $92.03 | 185,000 | $17,025,994 | 121,515,804 | -0.2% |
| 2018-07-09 17:45 | 2018-07-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $87.44 | 180,000 | $15,738,300 | 121,700,804 | -0.1% |
| 2018-07-06 18:13 | 2018-07-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.62 | 170,000 | $14,725,740 | 121,880,804 | -0.1% |
| 2018-06-18 19:39 | 2018-06-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.65 | 180,000 | $15,597,720 | 122,050,804 | -0.1% |
| 2018-06-15 18:00 | 2018-06-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.31 | 107,698 | $9,295,414 | 122,230,804 | -0.1% |
| 2018-06-14 18:58 | 2018-06-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.27 | 11,104 | $957,953 | 122,338,502 | 0.0% |
| 2018-06-14 23:08 | 2018-06-14 | LLY | ELI LILLY & Co | Skovronsky Daniel | Officer; SVP, CSO, and Pres. LRL | Pharmaceutical Preparations | BUY | $86.22 | 10,000 | $862,200 | 55,199 | +22.1% |
| 2018-06-12 21:46 | 2018-06-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.38 | 51,198 | $4,422,637 | 122,349,606 | 0.0% |
| 2018-06-05 18:20 | 2018-06-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $85.13 | 135,478 | $11,532,565 | 122,400,804 | -0.1% |
| 2018-06-04 21:25 | 2018-06-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $85.31 | 39,522 | $3,371,661 | 122,536,282 | 0.0% |
| 2018-06-01 23:22 | 2018-05-31 | LLY | ELI LILLY & Co | Conterno Enrique A | Officer; SVP&Pres, LillyDiab & LillyUSA | Pharmaceutical Preparations | SALE | $85.00 | 25,000 | $2,125,000 | 124,534 | -16.7% |
| 2018-05-31 20:18 | 2018-05-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $83.85 | 180,000 | $15,092,640 | 122,575,804 | -0.1% |
| 2018-05-31 20:05 | 2018-05-29 | LLY | ELI LILLY & Co | Shaw Christi | Officer; SVP and Pres., Lilly Bio-Meds | Pharmaceutical Preparations | SALE | $82.10 | 8,426 | $691,775 | 0 | -100.0% |
| 2018-05-14 21:29 | 2018-05-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $81.97 | 140,000 | $11,475,940 | 122,755,804 | -0.1% |
| 2018-05-03 23:34 | 2018-05-03 | LLY | ELI LILLY & Co | Simmons Jeffrey N | Officer; SVP&Pres. Elanco Animal Health | Pharmaceutical Preparations | OPT+S | $78.50 | 9,027 | $708,620 | 135,458 | -6.2% |
| 2018-04-26 19:38 | 2018-04-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $80.85 | 180,000 | $14,553,612 | 122,895,804 | -0.1% |
| 2018-04-17 22:29 | 2018-04-13 | LLY | ELI LILLY & Co | Mahony Susan | Officer; SVP & Pres., Lilly Oncology | Pharmaceutical Preparations | SALE | $80.09 | 22,544 | $1,805,632 | 28,273 | -44.4% |
| 2018-03-20 19:06 | 2018-03-16 | LLY | ELI LILLY & Co | Smiley Joshua L | Officer; SVP and CFO | Pharmaceutical Preparations | SALE | $79.20 | 3,000 | $237,600 | 20,029 | -13.0% |
| 2018-03-05 23:30 | 2018-03-01 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $76.50 | 860 | $65,790 | 1,637 | -34.4% |
| 2018-02-24 01:42 | 2018-02-21 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $77.55 | 876 | $67,934 | 2,472 | -26.2% |
| 2018-02-06 02:39 | 2018-02-05 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $81.09 | 900 | $72,981 | 4,130 | -17.9% |
| 2018-02-06 02:37 | 2018-02-05 | LLY | ELI LILLY & Co | Simmons Jeffrey N | Officer; SVP&Pres. Elanco Animal Health | Pharmaceutical Preparations | OPT+S | $81.12 | 9,625 | $780,780 | 133,201 | -6.7% |
| 2017-12-14 19:26 | 2017-12-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $88.20 | 200,000 | $17,639,180 | 123,075,804 | -0.2% |
| 2017-12-13 23:01 | 2017-12-11 | LLY | ELI LILLY & Co | Simmons Jeffrey N | Officer; SVP&Pres. Elanco Animal Health | Pharmaceutical Preparations | SALE | $86.46 | 12,500 | $1,080,750 | 124,522 | -9.1% |
| 2017-12-06 01:35 | 2017-12-04 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $86.00 | 3,532 | $303,752 | 40,048 | -8.1% |
| 2017-12-06 01:32 | 2017-12-04 | LLY | ELI LILLY & Co | Mahony Susan | Officer; SVP & Pres., Lilly Oncology | Pharmaceutical Preparations | SALE | $86.18 | 36,585 | $3,152,895 | 54,885 | -40.0% |
| 2017-11-13 20:55 | 2017-11-10 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $83.67 | 2,003 | $167,591 | 43,580 | -4.4% |
| 2017-10-05 21:56 | 2017-10-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $86.81 | 205,000 | $17,795,025 | 123,275,804 | -0.2% |
| 2017-10-02 22:39 | 2017-09-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $85.14 | 195,000 | $16,602,593 | 123,480,804 | -0.2% |
| 2017-09-18 22:42 | 2017-09-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $82.53 | 190,000 | $15,679,769 | 123,675,804 | -0.2% |
| 2017-09-01 20:45 | 2017-08-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $81.06 | 180,000 | $14,590,080 | 123,865,804 | -0.1% |
| 2017-08-01 17:55 | 2017-07-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $83.09 | 220,000 | $18,279,470 | 124,045,804 | -0.2% |
| 2017-06-23 17:16 | 2017-06-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $84.43 | 210,000 | $17,730,720 | 124,265,804 | -0.2% |
| 2017-06-21 18:24 | 2017-06-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $83.05 | 215,000 | $17,855,363 | 124,475,804 | -0.2% |
| 2017-06-13 23:10 | 2017-06-12 | LLY | ELI LILLY & Co | Barnes Melissa S | Officer; Chief Eth/Cmpl Ofcr & SVP, ERM | Pharmaceutical Preparations | SALE | $80.78 | 1,900 | $153,482 | 14,041 | -11.9% |
| 2017-06-09 23:15 | 2017-06-09 | LLY | ELI LILLY & Co | Harrington Michael J | Officer; Senior VP and General Counsel | Pharmaceutical Preparations | SALE | $79.97 | 22,833 | $1,825,955 | 62,056 | -26.9% |
| 2017-05-08 22:44 | 2017-05-04 | LLY | ELI LILLY & Co | Conterno Enrique A | Officer; SVP&Pres, LillyDiab & LillyUSA | Pharmaceutical Preparations | SALE | $82.76 | 25,000 | $2,069,000 | 114,217 | -18.0% |
| 2017-03-31 18:11 | 2017-03-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $84.67 | 210,000 | $17,781,540 | 124,690,804 | -0.2% |
| 2017-02-28 21:21 | 2017-02-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $83.06 | 225,000 | $18,688,950 | 124,900,804 | -0.2% |
| 2017-02-21 23:45 | 2017-02-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $80.27 | 230,000 | $18,462,790 | 125,125,804 | -0.2% |
| 2017-02-08 18:02 | 2017-02-06 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP& Pres., Emerging Markets | Pharmaceutical Preparations | SALE | $77.66 | 15,000 | $1,164,900 | 45,583 | -24.8% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.